Metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta‐analysis
R Bhandari, GA Kelley, TA Hartley… - International journal of …, 2014 - Wiley Online Library
Background. Although individual metabolic risk factors are reported to be associated with
breast cancer risk, controversy surrounds risk of breast cancer from metabolic syndrome …
breast cancer risk, controversy surrounds risk of breast cancer from metabolic syndrome …
Metabolic syndrome and breast cancer: is there a link?
D Hauner, H Hauner - Breast care, 2014 - karger.com
Epidemiological data suggest a close link between obesity and breast cancer, the most
frequently occurring cancer in women. The metabolic syndrome is typically associated with …
frequently occurring cancer in women. The metabolic syndrome is typically associated with …
Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk
M His, L Zelek, M Deschasaux, C Pouchieu… - European journal of …, 2014 - Springer
Experimental studies provided evidence about mechanisms by which cholesterol, especially
high density lipoprotein cholesterol (HDL-C), could influence carcinogenesis, notably …
high density lipoprotein cholesterol (HDL-C), could influence carcinogenesis, notably …
Metabolic syndrome and outcomes following early-stage breast cancer
GS Calip, KE Malone, JR Gralow, A Stergachis… - Breast cancer research …, 2014 - Springer
The prevalence of risk factors contributing to metabolic syndrome (MetS) is increasing, and
numerous components of MetS are associated with increased primary breast cancer (BC) …
numerous components of MetS are associated with increased primary breast cancer (BC) …
DPP-4 inhibitors: pharmacological differences and their clinical implications
A Ceriello, L Sportiello, C Rafaniello… - Expert opinion on drug …, 2014 - Taylor & Francis
Introduction: Recently, incretin-based therapy was introduced for the treatment of type 2
diabetes (T2D). In particular, dipeptidyl peptidase-4 inhibitors (DPP-4i)(sitagliptin …
diabetes (T2D). In particular, dipeptidyl peptidase-4 inhibitors (DPP-4i)(sitagliptin …
Metabolic syndrome and renal cell carcinoma
GM Zhang, Y Zhu, DW Ye - World journal of surgical oncology, 2014 - Springer
Background Metabolic syndrome (MS) is a cluster of metabolic abnormalities, which has
been regarded as a pivotal risk factor for cardiovascular diseases. Recent studies focusing …
been regarded as a pivotal risk factor for cardiovascular diseases. Recent studies focusing …
Síndrome metabólico en la menopausia, conceptos clave
S Rojas, JS Lopera, J Cardona, N Vargas… - Revista chilena de …, 2014 - SciELO Chile
La transición que experimenta la mujer durante la menopausia se asocia con el desarrollo
de características propias del síndrome metabólico (SM), entre las que se encuentran …
de características propias del síndrome metabólico (SM), entre las que se encuentran …
Metabolic syndrome and cancer: holistic or reductionist?
Metabolic syndrome has become a major public health problem worldwide and represents a
common clinical condition in countries with a high incidence of obesity and western dietary …
common clinical condition in countries with a high incidence of obesity and western dietary …
Unhealthy diets: a common soil for the association of metabolic syndrome and cancer
The association between metabolic syndrome and cancer continues to be acknowledged.
Metabolic syndrome is a common long-term complication in cancer survivors; on the other …
Metabolic syndrome is a common long-term complication in cancer survivors; on the other …
Menopause and metabolic syndrome in obese individuals with binge eating disorder
Menopausal transition has been associated with the emergence of metabolic abnormalities,
which may increase risk for chronic medical conditions in women. This study compared …
which may increase risk for chronic medical conditions in women. This study compared …